<DOC>
	<DOC>NCT02083133</DOC>
	<brief_summary>The purpose of this study is to assess whether the current recommendation for a 50% dose reduction in insulin for diabetic patients with a creatinine clearance (CrCl) ≤15 mL/min or on hemodialysis results in an increased number of hypoglycemic episodes.</brief_summary>
	<brief_title>Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Inpatient men and women 18 years of age and older with a diagnosis of type 2 diabetes mellitus (T2DM) with CrCl ≥60, 1659 or ≤15 milliliters/minute. Patients less than 18 years of age, pregnant patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Renal Failure</keyword>
	<keyword>Dialysis</keyword>
	<keyword>End Stage Renal Disease</keyword>
	<keyword>Hypoglycemia</keyword>
</DOC>